3Caramori ML, Mauer M. Diabetes and nephropathy [ J]. Curr Opin Nephrol Hypertens, 2003, 12 (3): 273-277.
4Haffner SM, Lehto S, Ronnemaa T, et al. Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and withoutprior myocardial infarction [J]. N Engl J Med, 1995, 339 (4) : 229- 234.
5Laakso M. Dyslipidemia, morbidity, and mortality in non-insulin-dependent diabetes mellitus. Lipoprotein and coronary heart disease in non- insulin-dependent diabetes mellitus [J]. J Diabetes Complications, 2002, 11 (2): 137-144.
8Niskanen L, Turpeinen A, Uusitupa MI, et al. Hyperglycemias and compositional lipoprotein abnormalities as predictors of cardiovascular mortality in type 2 diabetes: a 15-year follow-up from the time of diagnosis [J]. Diabetes Care, 1998, 21 (2): 1861- 1869.
10Kilax B, Meynet MC, Garin MC, et al. The apolipoprotein epsilon 2 allele and the severity of coronary artery disease in Type 2 diabetic patients [J]. Diabet Med, 2001, 18 (6): 445-449.
8Hariawala MD, Deshmukh VV, Sellke FW. Insulin resistance: A common factor in the triad of dyslipidemia , hypertension, and coronary artery disease? [J]. Am J Med Sci, 1997, 313:106 ～ 108.
9Rangenathen G, Lio C, Kern RA. The translational regulation of lipoprotein lipese in diabeticrats involves the 3 untranslated region of the LPL mRNA. J Biol Chem 2000, 6 (record as suppled by publisher).
10Memon RA, Tecott LH, Nonogaki K, et al. Up-regulation of peroxisome preliferator-activated receptors (PPAR-aplha) and PPAR-gamma messeager ribonucleic acid epression n the liver in murine obesity: triglitazone induces expression of PPAR-gammaresponsive adipose tissue-specific genes in the liver of obese diabetic mice. Endocrinology 2000,141(11) :4021.
